☆ 4.6 Article

Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT

DIAGNOSTICS (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients

Christian Uprimny et al.

Summary: This study aimed to assess the impact of intravenous hydration and furosemide diuresis at different dosages on tracer accumulation and halo artefact in urinary system. Results showed that 20mg furosemide and 500ml sodium chloride significantly reduced bladder halo artefacts and tracer accumulation intensity in [Ga-68]Ga-PSMA-11-PET/CT scans.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations

Yanna-Marina Chevalme et al.

Summary: The study compared the performance of PSMA-11 PET/CT in patients with BCR who previously had negative or equivocal FCH PET/CT. The study found that the PR of PSMA-11 was influenced by various factors including sPSA levels, patients' age, initial therapy, and the results of FCH PET/CT. Different imaging protocols for PSMA-11 PET/CT did not significantly affect the PR, and no adverse events were reported after PSMA-11 injection.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

Francesco Ceci et al.

Summary: The development of consensus guidelines for interpretation of PSMA-PET aims to provide consistent clinical reports, increase data reproducibility in clinical trials, and assist clinicians in making treatment decisions. An expert panel actively participated in a modified Delphi consensus process to implement structured reporting for PSMA-PET. The E-PSMA standardized reporting guidelines supported by the European Association of Nuclear Medicine offer consensus statements among experts in PSMA-PET imaging to harmonize diagnostic interpretation criteria.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake

Ian Alberts et al.

Summary: This study compared traditional and modified PSMA PET/CT imaging protocols, with the new protocol incorporating additional late imaging, hydration, and forced diuresis. The results showed that the new protocol led to significantly reduced bladder activity and increased lesion uptake and contrast in late scans, improving the visibility and diagnostic accuracy of locally recurring prostate cancer.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT

Christian Uprimny et al.

Summary: This study aimed to assess the impact of forced diuresis with early furosemide injection on the detection rate of local recurrence in prostate cancer patients with biochemical recurrence referred for Ga-68-PSMA-11 PET/CT, as well as determine whether the injection of furosemide shortly after tracer injection increases renal washout of Ga-68-PSMA-11.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol

Fabian Haupt et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Multiphasic 68Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients

Mohsen Beheshti et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

添加到收藏夹

Article Oncology

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

Wolfgang P. Fendler et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer

Bogdan Mitran et al.

CANCERS (2019)

添加到收藏夹

Article Medicine, General & Internal

68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?

Christian Uprimny

WIENER MEDIZINISCHE WOCHENSCHRIFT (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Matthias Eiber et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions

Christian Uprimny et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI

Martin T. Freitag et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence

Christian Uprimny et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

Wolfgang P. Fendler et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

Christian Uprimny et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions

Stefano Fanti et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Frusemide aids diagnostic interpretation of 68Ga-PSMA positron emission tomography/CT in men with prostate cancer

Niall Fennessy et al.

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

PSMA Ligands for PET Imaging of Prostate Cancer

Sarah M. Schwarzenboeck et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer

Ali Afshar-Oromieh et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging

Levent Kabasakal et al.

NUCLEAR MEDICINE COMMUNICATIONS (2015)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

A. Afshar-Oromieh et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.